1,173
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Antimelanoma and radioprotective activity of alcoholic aqueous extract of different species of Ocimum in C57BL mice

, , &
Pages 428-436 | Received 05 Apr 2010, Accepted 02 Sep 2010, Published online: 24 Mar 2011
 

Abstract

Context: Various Ocimum species (Labiateae) are commonly used for the treatment of inflammation, stress, diarrhea, and as an antioxidant drug in the Indian ethnic system of medicine.

Objective: The present study was carried out to investigate the antimelanoma and radioprotective activity of different species of Ocimum in C57BL and Swiss albino mice.

Materials and methods: The antimelanoma activity of 50% alcoholic aqueous leaf extract of five species of Ocimum [Ocimum sanctum (SE), Ocimum gratissimum (GE), Ocimum basilicum (BE), Ocimum canum (CE), and Ocimum kilimandscharicum (KE)] alone or in combination with radiotherapy was determined on the basis of tumor volume, body weight, and survival rate of animals. The radioprotective potential of different species of Ocimum was determined by chromosomal aberration assay. The effect of the alcoholic aqueous extract of different species of Ocimum was also evaluated for the estimation of glutathione level and glutathione S-transferase activity in Swiss albino mice.

Results: The 50% alcoholic aqueous extract of different species of Ocimum administered orally (200 mg/kg, p.o.) resulted in significant reduction in tumor volume, increase in average body weight, and survival rate of mice. The various extracts showed modulatory influence against lethal irradiation doses of gamma radiation in terms of radiation-induced chromosomal damage, while at the same time induced an increase in reduced glutathione level and GST activity.

Discussion and conclusion: These findings demonstrate that Ocimum species have antimelanoma and radioprotective activity against B16F10 metastatic melanoma cell line-induced metastasis and could be exploited as one of the potential sources for plant-based pharmaceutical products.

Acknowledgements

The authors are grateful to Shri Madan Mohan Joshi, Chairman of the Jawaharlal Nehru Cancer Hospital and Research Center, Bhopal, for providing facilities to carry out the work. Sanjeev Vashistha and Nancy, Department of Radiation Biology and Radioprotection, are acknowledged gratefully for irradiation facilities and dosimetric calculations.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.